Events and Webinars

Markets stand at a pivotal crossroads, where robust earnings and the promise of artificial intelligence-driven productivity balance the headwinds of a slowing economy and stretched valuations—all under the watchful eye of an accommodative Fed.

We invite you to join us for The Analyst Spotlight, a quarterly webinar series that allows you to hear directly from the experts behind our Structured Research Equity strategies, offered in the U.S. and Canada as US Equity Research.

Join us for a timely update with our US Mid-Cap Growth Equity Strategy team. Incoming Lead Portfolio Manager Ashley Woodruff will be joined by Co-portfolio Manager Don Easley and Portfolio Specialist Brian Dausch. 

Join us for the latest edition of our bi-annual webinar series ‘Ahead of the Curve’, where we will explore the intricate interplay between global bond markets, fiscal policies and economic planning. This sovereign debt centered webinar will analyse how bond markets function as potent catalysts in shaping financial strategies, and the opportunities and risks this presents to investors.

Join Sébastien Page, T. Rowe Price’s head of Global Multi-Asset and CIO; moderator Christina Noonan, multi-asset portfolio manager; and our special guest Dominic Rizzo, global technology equity portfolio manager, to discuss challenges, opportunities, and portfolio positioning in this dynamic environment.

We invite you to join Investment Analyst Lee Sandquist, who covers companies within industrials, industrials tech, and autos. While his coverage is composed of very different types of companies, Lee maintains a consistent focus on finding businesses with pricing power, which he believes will be better placed to tolerate a potential recession in a world of tariffs and elevated inflation.

Biotech stocks have struggled as a group, but the pace of drug discovery is accelerating. In this episode of “The Angle,” Sal Rais joins Jennifer Martin to explore how new ways of treating disease are improving human health and how breakthrough drugs can create value for some biotech innovators.

Featuring special guest Eric Veiel, head of Global Investments and CIO, hosted by T. Rowe Price's Multi-Asset Division focused on navigating the current uncertain policy environment and tactical asset allocation positioning.